From a clinical point of view, there is no doubt about the high thrombogenicity of SARS-CoV-2 due to endothelial dysfunction (7), causing elevated levels of prothrombotic substances such as D-dimer or VWF in critical COVID-19 patients. Here, VWF is linked to COVID-19.